Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297983818> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4297983818 abstract "Abstract Backgrround The randomized trials include ACOSOG Z0011 and IBCSG 23 − 01 had found that, the survival rates were not different in patients with cT1/2N0 and 1–2 sentinel lymph node (SLN) positive, macro/micro metastases who underwent breast-conserving therapy and micrometastases who underwent total mastectomy (TM), when axillary lymph node dissection (ALND) was omitted. However, for patients with cT1/2N0 and 1–2 SLN macrometastases who underwent TM, there was no published clinical research evidence whether ALND can be exempted. This study aimed to investigate the risk factors of non-sentinel lymph node (nSLN) metastasis in breast cancer patients with 1–2 SLN macrometastases undergoing TM. Methods The clinicopathological data of 1491 breast cancer patients underwent TM and SLNB from January 2017 to February 2022 were retrospectively analyzed. Univariate and multivariate analyses were performed to analyze the risk factors for nSLN metastasis. Results A total of 273 patients with 1–2 SLN macrometastases underwent TM were enrolled. Postoperative pathological data showed that 35.2% patients had nSLN metastasis. The results of multivariate analysis indicated that tumor size (TS) (P = 0.002; OR: 1.051; 95% CI: 1.019–1.084) and ratio of SLN macrometastases (P = 0.0001; OR: 12.597: 95% CI: 4.302–36.890) were the independent risk factors for nSLN metastasis in breast cancer with 1–2 SLN macrometastases underwent TM. The ROC curve analysis suggested that when TS ≤ 22mm and ratio of SLN macrometastases ≤ 0.33, the incidence of nSLN metastasis could be reduced to 17.1%. Conclusions The breast cancer patients with cT1/2N0 stage, undergoing TM and 1–2 SLN macrometastases, when the TS ≤ 22mm and macrometastatic SLN does not exceed 1/3 of the total number of detected SLN, the incidence of nSLN metastasis is significantly reduced, and whether ALND can be exempted deserves further exploration." @default.
- W4297983818 created "2022-10-01" @default.
- W4297983818 creator A5000333169 @default.
- W4297983818 creator A5001023087 @default.
- W4297983818 creator A5004906645 @default.
- W4297983818 creator A5011779197 @default.
- W4297983818 creator A5012920727 @default.
- W4297983818 creator A5037294705 @default.
- W4297983818 creator A5043102062 @default.
- W4297983818 creator A5068634436 @default.
- W4297983818 creator A5069412876 @default.
- W4297983818 creator A5086718911 @default.
- W4297983818 date "2022-09-29" @default.
- W4297983818 modified "2023-10-18" @default.
- W4297983818 title "Risk factors of non-sentinel lymph node metastasis in breast cancer with 1–2 sentinel lymph node micrometastases: a case control study" @default.
- W4297983818 cites W1975754193 @default.
- W4297983818 cites W2063199586 @default.
- W4297983818 cites W2095471137 @default.
- W4297983818 cites W2133600415 @default.
- W4297983818 cites W2516525501 @default.
- W4297983818 cites W2619961270 @default.
- W4297983818 cites W2891089580 @default.
- W4297983818 cites W2899452833 @default.
- W4297983818 cites W2943152293 @default.
- W4297983818 cites W2943226966 @default.
- W4297983818 cites W3033692494 @default.
- W4297983818 cites W3120492104 @default.
- W4297983818 cites W3214787579 @default.
- W4297983818 cites W4214486697 @default.
- W4297983818 cites W4280558464 @default.
- W4297983818 doi "https://doi.org/10.21203/rs.3.rs-2091343/v1" @default.
- W4297983818 hasPublicationYear "2022" @default.
- W4297983818 type Work @default.
- W4297983818 citedByCount "0" @default.
- W4297983818 crossrefType "posted-content" @default.
- W4297983818 hasAuthorship W4297983818A5000333169 @default.
- W4297983818 hasAuthorship W4297983818A5001023087 @default.
- W4297983818 hasAuthorship W4297983818A5004906645 @default.
- W4297983818 hasAuthorship W4297983818A5011779197 @default.
- W4297983818 hasAuthorship W4297983818A5012920727 @default.
- W4297983818 hasAuthorship W4297983818A5037294705 @default.
- W4297983818 hasAuthorship W4297983818A5043102062 @default.
- W4297983818 hasAuthorship W4297983818A5068634436 @default.
- W4297983818 hasAuthorship W4297983818A5069412876 @default.
- W4297983818 hasAuthorship W4297983818A5086718911 @default.
- W4297983818 hasBestOaLocation W42979838181 @default.
- W4297983818 hasConcept C121608353 @default.
- W4297983818 hasConcept C126322002 @default.
- W4297983818 hasConcept C126838900 @default.
- W4297983818 hasConcept C143998085 @default.
- W4297983818 hasConcept C2779013556 @default.
- W4297983818 hasConcept C2780212769 @default.
- W4297983818 hasConcept C2908949552 @default.
- W4297983818 hasConcept C530470458 @default.
- W4297983818 hasConcept C71924100 @default.
- W4297983818 hasConceptScore W4297983818C121608353 @default.
- W4297983818 hasConceptScore W4297983818C126322002 @default.
- W4297983818 hasConceptScore W4297983818C126838900 @default.
- W4297983818 hasConceptScore W4297983818C143998085 @default.
- W4297983818 hasConceptScore W4297983818C2779013556 @default.
- W4297983818 hasConceptScore W4297983818C2780212769 @default.
- W4297983818 hasConceptScore W4297983818C2908949552 @default.
- W4297983818 hasConceptScore W4297983818C530470458 @default.
- W4297983818 hasConceptScore W4297983818C71924100 @default.
- W4297983818 hasLocation W42979838181 @default.
- W4297983818 hasOpenAccess W4297983818 @default.
- W4297983818 hasPrimaryLocation W42979838181 @default.
- W4297983818 hasRelatedWork W2017282305 @default.
- W4297983818 hasRelatedWork W2204147331 @default.
- W4297983818 hasRelatedWork W2322084592 @default.
- W4297983818 hasRelatedWork W2348921775 @default.
- W4297983818 hasRelatedWork W2801853910 @default.
- W4297983818 hasRelatedWork W3029617671 @default.
- W4297983818 hasRelatedWork W3030154484 @default.
- W4297983818 hasRelatedWork W3032270333 @default.
- W4297983818 hasRelatedWork W3193545560 @default.
- W4297983818 hasRelatedWork W3200885630 @default.
- W4297983818 isParatext "false" @default.
- W4297983818 isRetracted "false" @default.
- W4297983818 workType "article" @default.